| Kaitlin Michelle Kellar, APRN | |
|
71380 Highway 21, Covington, LA 70433-7122 | |
| (985) 373-6512 | |
| Not Available |
| Full Name | Kaitlin Michelle Kellar |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Women's Health |
| Location | 71380 Highway 21, Covington, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700660255 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 227174 (Louisiana) | Secondary |
| 363LW0102X | Nurse Practitioner - Women's Health | 227174 (Louisiana) | Primary |
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Johns Hopkins scientists were dubious in the early 1980s when they stumbled on small sugar molecules lurking in the centers of cells; not only were they not supposed to be there, but they certainly weren't supposed to be repeatedly attaching to and detaching from proteins, effectively switching them on and off.
Two new studies demonstrate potential future opportunities to use genetic information to treat vision conditions. The new studies are being presented at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology in Honolulu, Hawaii, Sunday, April 29 – Thursday, May 3.
A pilot study has begun to assess the antibody response to a third dose of an authorized COVID-19 mRNA vaccine in kidney transplant recipients who did not respond to two doses of the Moderna or Pfizer-BioNTech COVID-19 vaccine.
In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breastfeeding to do so, at least for a few months—long enough for mother and child to gain health benefits.
CellTherapeutics today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Pixuvri is the first approved treatment in the European Union in this patient setting.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaitlin Michelle Kellar, APRN 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Kaitlin Michelle Kellar, APRN 71380 Highway 21, Covington, LA 70433-7122 Ph: (985) 373-6512 |
News Archive
Johns Hopkins scientists were dubious in the early 1980s when they stumbled on small sugar molecules lurking in the centers of cells; not only were they not supposed to be there, but they certainly weren't supposed to be repeatedly attaching to and detaching from proteins, effectively switching them on and off.
Two new studies demonstrate potential future opportunities to use genetic information to treat vision conditions. The new studies are being presented at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology in Honolulu, Hawaii, Sunday, April 29 – Thursday, May 3.
A pilot study has begun to assess the antibody response to a third dose of an authorized COVID-19 mRNA vaccine in kidney transplant recipients who did not respond to two doses of the Moderna or Pfizer-BioNTech COVID-19 vaccine.
In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breastfeeding to do so, at least for a few months—long enough for mother and child to gain health benefits.
CellTherapeutics today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Pixuvri is the first approved treatment in the European Union in this patient setting.
› Verified 4 days ago
Sunny R Mcdaniel, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 120 Innwood Dr, Covington, LA 70433 Phone: 985-892-3225 Fax: 985-892-7677 | |
Ashley Pinion Bratton, APRN, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 19345 Sunshine Ave, Covington, LA 70433 Phone: 985-246-3053 | |
Mr. Luis Benigno Martinez Iii, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1850 N Highway 190, Covington, LA 70433 Phone: 985-809-1515 | |
Jeffrey J Stein, ACNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1970 N Hwy 190, Covington, LA 70433 Phone: 985-867-8585 Fax: 985-867-3644 | |
Dionne M Stein, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1970 N. Hwy 190, Covington, LA 70433 Phone: 985-867-8585 Fax: 985-867-3644 | |
Stacy Sharp, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 20 Starbrush Cir, Covington, LA 70433 Phone: 985-871-6020 | |
Colleen Leo Frady, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1970 N Highway 190, Covington, LA 70433 Phone: 985-867-8585 Fax: 985-867-3644 |